EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Maternal cell contamination in postnatal umbilical cord blood samples implies a low risk for genetic misdiagnoses

Sanne P Smeekens iD, Maike Leferink, Helger G Yntema, Erik-Jan Kamsteeg

Prenatal Diagnosis · 2024

DOI: 10.1002/pd.6595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prenatal Diagnosis, 2024. Verfasst von Sanne P Smeekens und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Radboudumc, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Fetal Blood, Diagnostic Errors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Maternal cell contamination (MCC) poses a risk for misdiagnosis in prenatal genetic testing, and is examined in accredited diagnostic laboratories However, the awareness of possible MCC in perinatal/postnatal genetic testing, mainly of umbilical cord blood (CB), is lower.

Method

We investigated the rate of MCC in DNA from both umbilical CB samples and umbilical cord samples that were sent to our diagnostic laboratory for diagnostic testing between 1995 and 2021 ( n = 236).

Results

MCC was detected in 4% of umbilical CB samples, and in one umbilical cord sample. Particularly tests enriching for a specific variant are very sensitive for low amounts of MCC, as we emphasize here with a false positive diagnosis of myotonic dystrophy type 1 in a newborn.

Conclusions

Overall, with appropriate collection and use, umbilical CB and umbilical cord samples are suitable for genetic testing based on the low rates of MCC and misdiagnosis. These findings do however underline the importance of routine MCC testing in umbilical CB samples and umbilical cord samples for both requesting clinicians and diagnostic genetic laboratories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal BloodDiagnostic ErrorsHumansFemalePregnancyInfant, NewbornGenetic TestingPrenatal DiagnosisDNA Contamination

Autor:innen und Institutionen

  • Department of Human Genetics, Radboudumc, Nijmegen, The Netherlands.

ORCID-Profile: Sanne P Smeekens

Zitieren

APA

Smeekens, S. P., Leferink, M., Yntema, H. G., & Kamsteeg, E. J. (2024). Maternal cell contamination in postnatal umbilical cord blood samples implies a low risk for genetic misdiagnoses. Prenatal Diagnosis. https://doi.org/10.1002/pd.6595

Vancouver

Smeekens SP, Leferink M, Yntema HG, Kamsteeg EJ. Maternal cell contamination in postnatal umbilical cord blood samples implies a low risk for genetic misdiagnoses. Prenatal Diagnosis. 2024. doi:10.1002/pd.6595

BibTeX
@article{Smeekens2024,
  author = {Smeekens, Sanne P and Leferink, Maike and Yntema, Helger G and Kamsteeg, Erik-Jan},
  title = {Maternal cell contamination in postnatal umbilical cord blood samples implies a low risk for genetic misdiagnoses},
  journal = {Prenatal Diagnosis},
  year = {2024},
  doi = {10.1002/pd.6595}
}
Kostenlos starten →